Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: ksuave who wrote (59403)	12/7/2006 8:37:45 PM
From: ACAN	Respond to of 120409

ksuave; I agree, it will certainly increase their footprint.This is not something that 3M would enter into lightly. Allan

To: ksuave who wrote (59403)	12/8/2006 12:04:04 AM
From: Stuki	Respond to of 120409

RPBIF This is great news to be connected to 3M's medical division. When I spoke with Rob Pilz back on 10/30/06 he said they were looking to partner for sales and distribution. It looks like 3M is it. He also said back then that their diagnostic for congestive heart failure has also been established as a marker for prognosis in ACS (Acute Coronary Syndrome)and if their tests continue to show terrific data they could be marketing it by 2Q 2007 in the USA, the EU earlier and perhaps in China. Pilz mentioned it should be a different company by 2Q 2007. He said their RAMP technology has shown great results where ever they applied it. The company fully diluted is roughly 120 M shares, O/S about 98 M and float of about 48 M. 3M's equity investment consists of 14,797,419 shares at a price of Canadian $0.62 per share. 3M has agreed not to sell any of its shares for a period of 12 months from closing. For a one - year period, 3M shall have a pro rata right, based on their percentage equity ownership in the Company, on a fully diluted basis, to participate in subsequent issuances of equity securities of the Company. Hopefully their will be no more dilution.